2015

  1. Methotrexate in pediatric CD

  2. Allogeneic Bone Marrow–Derived Mesenchymal Stromal Cells in Perianal Fistulas in CD

  3. Mongersen, an Oral *SMAD7* Antisense Oligonucleotide, and Crohn’s Disease

  4. Post operative recurrence in CD active care or standard care

  5. Intravenous golimumab induction therapy for ulcerative colitis

  6. Early combo (antiTNF+antimetabolite) treatment vs conventional in CD

  7. Therapeutic Targets in IBD

  8. Thalidomide in pediatric UC

  9. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

  10. Infliximab dosage in IBD